Publications

  1. Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR, Suksanpaisan L, O'Connor MK, Freeman BL, Ibrahim SH, Peng KW, Harding CO, Ho CS, Grompe M, Ikeda Y, Lillegard JB, Russell SJ, Nyberg SL. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Sci Transl Med 2016 Jul 27; 8 (349):349ra99
    View PubMed
  2. Ibrahim SH, Hirsova P, Malhi H, Gores GJ. Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame. Dig Dis Sci 2016 May; 61 (5):1325-36 Epub 2015 Dec 01
    View PubMed
  3. Ibrahim SH. Omega-3 Fatty Acid-rich Parenteral Nutrition: Is It a Double-edged Sword? J Pediatr Gastroenterol Nutr 2016 May; 62 (5):e46-7
    View PubMed
  4. Hirsova P, Ibrahim SH, Gores GJ, Malhi H. Lipotoxic Lethal and Sublethal Stress Signaling in Hepatocytes: Relevance to NASH Pathogenesis. J Lipid Res 2016 Apr 5 Epub 2016 Apr 05
    View PubMed
  5. Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. Gastroenterology 2016 Apr; 150 (4):956-67 Epub 2016 Jan 05
    View PubMed
  6. Ibrahim SH, Hirsova P, Tomita K, Bronk SF, Werneburg NW, Harrison SA, Goodfellow VS, Malhi H, Gores GJ. Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology 2016 Mar; 63 (3):731-44 Epub 2015 Dec 11
    View PubMed
  7. Tomita K, Freeman BL, Bronk SF, LeBrasseur NK, White TA, Hirsova P, Ibrahim SH. CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis. Sci Rep 2016; 6:28786 Epub 2016 June 28
    View PubMed
  8. Ibrahim SH, Gores GJ, Hirsova P, Kirby M, Miles L, Jaeschke A, Kohli R. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Liver Int 2014 Mar; 34 (3):427-37 Epub 2013 Nov 20
    View PubMed
  9. Kohli R, Setchell KD, Kirby M, Myronovych A, Ryan KK, Ibrahim SH, Berger J, Smith K, Toure M, Woods SC, Seeley RJ. A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery. Endocrinology. 2013 Jul; 154(7):2341-51. Epub 2013 Apr 16.
    View PubMed
  10. Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS One 2013; 8 (7):e70599 Epub 2013 July 22
    View PubMed
  11. Hamouda NM, Grothe RM, Ibrahim SH. Multiple liver lesions in an immunosuppressed patient: is infection always the answer? Case Rep Gastroenterol. 2013; 7(2):327-31. Epub 2013 Aug 16.
    View PubMed
  12. Ibrahim SH, Kohli R, Gores GJ. Mechanisms of lipotoxicity in NAFLD and clinical implications. J Pediatr Gastroenterol Nutr. 2011 Aug; 53(2):131-40.
    View PubMed
  13. Ibrahim SH, Zhang L, Freese DK. A 3-year-old with immunoglobulin G4-associated cholangitis. J Pediatr Gastroenterol Nutr. 2011 Jul; 53(1):109-11.
    View PubMed
  14. Ibrahim SH, Lindor KD. Current management of primary sclerosing cholangitis in pediatric patients. Paediatr Drugs. 2011 Apr 1; 13(2):87-95.
    View PubMed
  15. Ibrahim SH, Akazawa Y, Cazanave SC, Bronk SF, Elmi NA, Werneburg NW, Billadeau DD, Gores GJ. Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosis. J Hepatol. 2011 Apr; 54(4):765-72. Epub 2010 Nov 23.
    View PubMed
  16. Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ. Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics. 2009 Aug; 124(2):680-6. Epub 2009 Jul 27.
    View PubMed
  17. Ibrahim SH, Smyrk TC, Faubion WA. Treatment of isolated gastric Crohn's disease with inhaled corticosteroids. Case Rep Gastroenterol. 2008; 2(3):363-8. Epub 2008 Nov 05.
    View PubMed